Evolent Health
EVH
$31.03
Share price
4.02%
Change (1 day)
2.14%
Change (1 year)
Categories
Revenue for Evolent Health (EVH)
Revenue in 2023 (TTM): $1.48 B
According to Evolent Health's latest financial reports the company's current revenue (TTM) is $1.48 B. In 2022 the company made a revenue of $1.35 B an increase over the years 2021 revenue that were of $0.90 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Evolent Health from 2014 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $1.48 B | 9.66% |
| 2022 | $1.35 B | 48.91% |
| 2021 | $0.90 B | -11.2% |
| 2020 | $1.02 B | 20.8% |
| 2019 | $0.84 B | 34.98% |
| 2018 | $0.62 B | 44.17% |
| 2017 | $0.43 B | 71.11% |
| 2016 | $0.25 B | 89.81% |
| 2015 | $0.13 B | 567.06% |
| 2014 | $20.07 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 National Healthcare
NHC | $1.07 B | -27.46% | 🇺🇸 USA |
 Global Cord Blood CO | $0.19 B | -86.92% | 🇭🇰 Hong Kong |
 Graham Holdings GHC | $4.04 B | 172.57% | 🇺🇸 USA |
 CryoLife CRY | $0.29 B | -79.84% | 🇺🇸 USA |